PCSK9 Inhibitors in Targeted Treatment of Hypercholesterolemia - April 26, 2016

Explore the latest advancements in treating hypercholesterolemia in this comprehensive Grand Rounds lecture delivered by Dr. Alan S. Brown, Director of the Division of Cardiology at Advocate Heart Institute. Delve into the role of PCSK9 inhibitors as part of a targeted treatment approach, gaining valuable insights from an expert in the field. Learn about the latest research, clinical applications, and potential benefits of this innovative class of drugs in managing high cholesterol levels. Enhance your understanding of cardiovascular medicine and stay up-to-date with cutting-edge therapeutic strategies in this hour-long presentation from the Mary Greeley Medical Center.

PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16